Co-relation of cerebral venous sinus thrombosis with vitamin B12 and homocysteine levels in a tertiary care centre

 

Sohan B^1*, Hamsa Manasa K²

 

REFERENCES

1. Bousser MG, Ferro JM. Cerebral venous thrombosis: An update. Lancet Neurol. 2007;6:162–70.
2. Brustolin S, Giugliani R, Félix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res 2010;43:1-7.
3. Tan KS, Lee TC, Tan CT: Hyperhomocysteinemia in patients with acute ischaemic stroke in Malaysia . Neurol J Southeast Asia. 2001, 6:113-119.
4. Okubadejo NU, Oladipo OO, Adeyomoye AA, Awosanya GO, Danesi MA: Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMCNeurol. 2008, 8:26.
5. Zhu BT. On the mechanism of homocysteine pathophysiology and pathogenesis: A unifying hypothesis. Histol Histopathol 2002;17:1283-91.
6. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-8.
7. Takemaru M, Kuriyama M, Himeno T, Shiga Y, Kanaya Y, et al. (2017) Cerebral Venous Sinus Thrombosis: Incidence and Hyperhomocysteinemia as a Risk Factor in Japanese Patients. J Neurol Neurosci. Vol. 8 No. 5:219
8. Dentali F, Crowther M, Ageno W (2006) Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: A metaanalysis. Blood 107: 2766-2773.
9. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT I: Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004, 35(3):664-670.
10. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM: Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003, 102(4):1363-1366.
11. Cantu C, Alonso E, Jara ABS, Martinez LBS, Rios CC, de los Angeles Fernandez,Maria B.Sc, Garcia IBS, Barinagarrementeria F: Hyperhomocysteinemia, Low Folate and Vitamin B12 Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis. Stroke 2004, 35(8):1790-1794.
12. Narayan D, Kaul S, Ravishankar K, Suryaprabha T, Bandaru VC, Mridula KR, et al. Risk factors, clinical profile, and long‑term outcome of 428 patients of cerebral sinus venous thrombosis: Insights from Nizam’s Institute Venous Stroke Registry, Hyderabad (India). Neurol India 2012;60:154‑9.
13. Chouksey D, Ishar HS, Jain R, Athale S, Sodani A. Association between serum homocysteine levels and methylene‑tetrahydrofolate‑reductase gene polymorphism in patients with stroke: A study from a tertiary care teaching hospital from central India. J Med Sci 2021;3:140-5.
14. Jayantee Kalita, Varun K. Singh and Usha Kant Misra, A study of hyperhomocysteinemia in cerebral venous sinus thrombosis, Indian J Med Res 152, December 2020, pp 584-594
15. Panigrahi I, Chatterjee T, Biswas A, Behari M, Choudhry PV, Saxena R. Role of MTHFR C677T polymorphism in ischemic stroke. Neurol India 2006;54:48-50
16. Kamran, Sanskriti and Sharma, Sanjay and Banerjee, Sayani and Das Thakur, Sujoy. (2021). Correlation Between Cerebral Venous Sinus Thrombosis And Serum Homocysteine Levels In A Tertiary Care Hospital, India A Prospective Observational Study. International Journal of Advanced Research. 9. 251-274.